ADBALYA Trademark
Serial Number: 99084951
ADBALYA is a trademark filed by
AstraZeneca AB
on March 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Cara M. Kearney AstraZeneca Pharmaceuticals LP
1800 Concord Pike, A2C
Wilmington, DE 19850-5437
United States
Trademark Details
Filing Date
March 14, 2025
Registration Date
Not Registered
Goods & Services
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Vaccines
Filing History
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 14, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 14, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 14, 2026 CNRT
EXAMINER'S AMENDMENT ENTERED
Apr 15, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 15, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 15, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 15, 2026 CNEA
ASSIGNED TO EXAMINER
Mar 2, 2026 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 17, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 3, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 3, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWOS
NEW APPLICATION ENTERED
Mar 14, 2025 NWAP
